Redox proteomics identification of specifically carbonylated proteins in the hippocampi of triple transgenic Alzheimer's disease mice at its earliest pathological stage

Journal of Proteomics

Volumn 123, Issue , 2015, Pages 101-113

  Shen, Liming ^a   Chen, Cheng ^a   Yang, Aochu ^a   Chen, Youjiao ^a   Liu, Qiong ^a   Ni, Jiazuan ^a  

^a SHENZHEN UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Hippocampus; Oxidative stress; Protein carbonylation; Redox proteomics; Triple transgenic mice

Indexed keywords

14 3 3 PROTEIN ZETA DELTA; ACONITATE HYDRATASE; ALPHA ENOLASE; BETA TUBULIN; CARBONYL DERIVATIVE; CARBONYL REDUCTASE; CARBONYL REDUCTASE 1; CHAPERONIN CONTAINING TCP1; GLUTAMATE AMMONIA LIGASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 90 BETA; MALATE DEHYDROGENASE; NEUROFILAMENT LIGHT POLYPEPTIDE; NEUROFILAMENT PROTEIN; PHOSPHOGLYCERATE KINASE; PHOSPHOGLYCERATE KINASE 1; PROTEIN; PROTEIN 14 3 3; PROTEIN DISULFIDE ISOMERASE; PROTEIN DISULFIDE ISOMERASE A3; T COMPLEX PROTEIN 1 SUBUNIT EPSILON; TUBULIN BETA 2A CHAIN; UNCLASSIFIED DRUG; ALCOHOL DEHYDROGENASE; CARBON; CARBONYL REDUCTASE 1, MOUSE; CCT5 PROTEIN, MOUSE; ENO1 PROTEIN, MOUSE; ENOLASE; PDIA3 PROTEIN, MOUSE;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DERIVATIZATION; DISEASE ASSOCIATION; ENERGY METABOLISM; EXCITOTOXICITY; HIPPOCAMPUS; IMMUNOPRECIPITATION; MALE; MILD COGNITIVE IMPAIRMENT; MOUSE; NEUROFIBRILLARY TANGLE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CARBONYLATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEOMICS; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; BIOLOGY; CHEMISTRY; COGNITIVE DEFECT; DISEASE MODEL; GENETICS; MASS SPECTROMETRY; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROCEDURES; TRANSGENIC MOUSE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

MUS; MUS MUSCULUS;

ALCOHOL OXIDOREDUCTASES; ALZHEIMER DISEASE; ANIMALS; CARBON; CHAPERONIN CONTAINING TCP-1; COGNITION DISORDERS; COMPUTATIONAL BIOLOGY; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GLUTAMATE-AMMONIA LIGASE; HIPPOCAMPUS; MALE; MASS SPECTROMETRY; MICE; MICE, TRANSGENIC; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHOSPHOPYRUVATE HYDRATASE; PROTEIN CARBONYLATION; PROTEIN DISULFIDE-ISOMERASES; PROTEIN FOLDING; PROTEIN INTERACTION MAPPING; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 84928333998     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2015.04.005     Document Type: Article

References (63)

1. Sato Y., Suzuki I., Nakamura T., Bernier F., Aoshima K., Oda Y. Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology. J Lipid Res 2012, 53(3):567-576.
2. Alzheimer's Association 2014 Alzheimer's disease facts and figures. Alzheimers Dement 2014, 10(2):e47-e92.
3. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J Neurochem 2006, 97(6):1634-1658.
4. Skoumalová A., Hort J. Blood markers of oxidative stress in Alzheimer's disease. J Cell Mol Med 2012, 16(10):2291-2300.
5. Butterfield D.A., Kanski J. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech Aging Dev 2001, 122(9):945-962.
6. Butterfield D.A., Lauderback C.M. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic Biol Med 2002, 32(11):1050-1060.
7. Mao P. Oxidative stress and its clinical applications in dementia. J Neurodegener Dis 2013, 2013:319898.
8. Praticò D., Uryu K., Leight S., Trojanoswki J.Q., Lee V.M. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 2001, 21(12):4183-4187.
9. Butterfield D.A., Reed T.T., Perluigi M., De Marco C., Coccia R., Keller J.N., et al. Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease. Brain Res 2007, 1148:243-248.
10. Berlett B.S., Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 1997, 272(33):20313-20316.
11. Sultana R., Butterfield D.A. Oxidative modification of brain proteins in Alzheimer's disease: perspective on future studies based on results of redox proteomics studies. J Alzheimers Dis 2013, 33(Suppl. 1):S243-S251.
12. Bradley M.A., Markesbery W.R., Lovell M.A. Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radic Biol Med 2010, 48(12):1570-1576.
13. Oddo S., Caccamo A., Kitazawa M., Tseng B.P., LaFerla F.M. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 2003, 24(8):1063-1070.
14. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39(3):409-421.
15. Carroll J.C., Rosario E.R., Chang L., Stanczyk F.Z., Oddo S., LaFerla F.M., et al. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3×Tg-AD mice. J Neurosci 2007, 27(48):13357-13365.
16. Oddo S., Caccamo A., Tran L., Lambert M.P., Glabe C.G., Klein W.L., et al. Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease: a link between Abeta and tau pathology. J Biol Chem 2006, 281(3):1599-1604.
17. Aluise C.D., Robinson R.A., Cai J., Pierce W.M., Markesbery W.R., Butterfield D.A. Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI. J Alzheimers Dis 2011, 23(2):257-269.
18. Conrad C.C., Choi J., Malakowsky C.A., Talent J.M., Dai R., Marshall P., et al. Identification of protein carbonyls after two-dimensional electrophoresis. Proteomics 2001, 1(7):829-834.
19. Wang Y., Cheung Y.H., Yang Z., Chiu J.F., Che C.M., He Q.Y. Proteomic approach to study the cytotoxicity of dioscin (saponin). Proteomics 2006, 6(8):2422-2432.
20. Wang J., Jiang J., Zhang H., Wang J., Cai H., Li C., et al. Integrated transcriptional and proteomic analysis with in vitro biochemical assay reveal the important role of CYP3A46 in T-2 toxin hydroxylation in porcine primary hepatocytes. Mol Cell Proteomics 2011, 10(9). (M111.008748).
21. Chen P., Wang C., Ma X., Zhang Y., Liu Q., Qiu S., et al. Direct interaction of selenoprotein R with clusterin and its possible role in Alzheimer's disease. PLoS One 2013, 8(6):e66384.
22. Conrad C.C., Talent J.M., Malakowsky C.A., Gracy R.W. Post-electrophoretic identification of oxidized proteins. Biol Proced Online 2000, 2:39-45.
23. Alam S.I., Bansod S., Kumar R.B., Sengupta N., Singh L. Differential proteomic analysis of Clostridium perfringens ATCC13124; identification of dominant, surface and structure associated proteins. BMC Microbiol 2009, 9:162.
24. Terra L.F., Teixeira P.C., Wailemann R.A., Zelanis A., Palmisano G., Cunha-Neto E., et al. Proteins differentially expressed in human beta-cells-enriched pancreatic islet cultures and human insulinomas. Mol Cell Endocrinol 2013, 381(1-2):16-25.
25. Butterfield D.A., Poon H.F., St Clair D., Keller J.N., Pierce W.M., Klein J.B., et al. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol Dis 2006, 22(2):223-232.
26. Sultana R., Boyd-Kimball D., Poon H.F., Cai J., Pierce W.M., Klein J.B., et al. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. Neurobiol Aging 2006, 27(11):1564-1576.
27. Sultana R., Robinson R.A., Domenico F.D., Abdul H.M., St Clair D., Markesbery W.R., et al. Proteomic identification of specifically carbonylated brain proteins in APPNLh/APPNLh×PS-1P264L/PS-1P264L human double mutant knock-in mice model of Alzheimer disease as a function of age. J Proteomics 2011, 74(11):2430-2440.
28. Sultana R., Reed T., Perluigi M., Coccia R., Pierce W.M., Butterfield D.A. Proteornic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study. J Cell Mol Med 2007, 11(4):839-851.
29. Castegna A., Aksenov M., Thongboonkerd V., Klein J.B., Pierce W.M., Booze R., et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J Neurochem 2002, 82(6):1524-1532.
30. Castegna A., Thongboonkerd V., Klein J.B., Lynn B., Markesbery W.R., Butterfield D.A. Proteomic identification of nitrated proteins in Alzheimer's disease brain. J Neurochem 2003, 85(6):1394-1401.
31. Reed T., Perluigi M., Sultana R., Pierce W.M., Klein J.B., Turner D.M., et al. Redox proteomic identification of 4- hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease. Neurobiol Dis 2008, 30(1):107-120.
32. Sultana R., Perluigi M., Butterfield D.A. Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42). J Chromatogr B Analyt Technol Biomed Life Sci 2006, 833(1):3-11.
33. Perluigi M., Sultana R., Cenini G., Di Domenico F., Memo M., Pierce W.M., et al. Redox proteomics identification of 4-hydroxynonenal-modified brain proteins in Alzheimer's disease: role of lipid peroxidation in Alzheimer's disease pathogenesis. Proteomics Clin Appl 2009, 3(6):682-693.
34. Sultana R., Poon H.F., Cai J., Pierce W.M., Merchant M., Klein J.B., et al. Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach. Neurobiol Dis 2006, 22(1):76-87.
35. Opii W.O., Joshi G., Head E., Milgram N.W., Muggenburg B.A., Klein J.B., et al. Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer's disease. Neurobiol Aging 2008, 29(1):51-70.
36. Boyd-Kimball D., Sultana R., Poon H.F., Mohmmad-Abdul H., Lynn B.C., Klein J.B., et al. Gamma-glutamylcysteine ethyl ester protection of proteins from Abeta(1-42)-mediated oxidative stress in neuronal cell culture: a proteomics approach. J Neurosci Res 2005, 79(5):707-713.
37. Sultana R., Perluigi M., Butterfield D.A. Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis. Acta Neuropathol 2009, 118(1):131-150.
38. Castegna A., Aksenov M., Aksenova M., Thongboonkerd V., Klein J.B., Pierce W.M., et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxyterminal hydrolase L-1. Free Radic Biol Med 2002, 33(4):562-571.
39. Boyd-Kimball D., Sultana R., Poon H.F., Lynn B.C., Casamenti F., Pepeu G., et al. Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid beta-peptide (1-42) into rat brain: implications for Alzheimer's disease. Neuroscience 2005, 132(2):313-324.
40. Boyd-Kimball D., Poon H.F., Lynn B.C., Cai J., Pierce W.M., Klein J.B., et al. Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human Abeta(1-42): implications for Alzheimer's disease. Neurobiol Aging 2006, 27(9):1239-1249.
41. Balcz B., Kirchner L., Cairns N., Fountoulakis M., Lubec G. Increased brain protein levels of carbonyl reductase and alcohol dehydrogenase in Down syndrome and Alzheimer's disease. J Neural Transm Suppl 2001, (61):193-201.
42. Sultana R., Perluigi M., Newman S.F., Pierce W.M., Cini C., Coccia R., et al. Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease. Antioxid Redox Signal 2010, 12(3):327-336.
43. Resende R., Moreira P.I., Proença T., Deshpande A., Busciglio J., Pereira C., et al. Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. Free Radic Biol Med 2008, 44(12):2051-2057.
44. Wang J.M., Singh C., Liu L., Irwin R.W., Chen S., Chung E.J., et al. Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 2010, 107(14):6498-6503.
45. Aluise C.D., Robinson R.A., Beckett T.L., Murphy M.P., Cai J., Pierce W.M., et al. Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics. Neurobiol Dis 2010, 39(2):221-228.
46. Yao J., Irwin R.W., Zhao L., Nilsen J., Hamilton R.T., Brinton R.D. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 2009, 106(34):14670-14675.
47. Ghosh D., LeVault K.R., Barnett A.J., Brewer G.J. A reversible early oxidized redox state that precedes macromolecular ROS damage in aging nontransgenic and 3×Tg-AD mouse neurons. J Neurosci 2012, 32(17):5821-5832.
48. Stadtman E.R., Berlett B.S. Reactive oxygen-mediated protein oxidation in aging and disease. Chem Res Toxicol 1997, 10(5):485-494.
49. Butterfield D.A., Lange M.L. Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism. J Neurochem 2009, 111(4):915-933.
50. Butterfield D.A., Hardas S.S., Lange M.L. Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration. J Alzheimers Dis 2010, 20(2):369-393.
51. Yan L.J., Levine R.L., Sohal R.S. Oxidative damage during aging targets mitochondrial aconitase. Proc Natl Acad Sci U S A 1997, 94(21):11168-11172.
52. Sultana R., Butterfield D.A. Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment. J Bioenerg Biomembr 2009, 41(5):441-446.
53. Erickson R.R., Dunning L.M., Olson D.A., Cohen S.J., Davis A.T., Wood W.G., et al. In cerebrospinal fluid ER chaperones ERp57 and calreticulin bind beta-amyloid. Biochem Biophys Res Commun 2005, 332(1):50-57.
54. Pendyala G., Ninemire C., Fox H.S. Protective role for the disulfide isomerase PDIA3 in methamphetamine neurotoxicity. PLoS One 2012, 7(6):e38909.
55. Brackley K.I., Grantham J. Activities of the chaperonin containing TCP-1 (CCT): implications for cell cycle progression and cytoskeletal organisation. Cell Stress Chaperones 2009, 14(1):23-31.
56. Bouhouche A., Benomar A., Bouslam N., Chkili T., Yahyaoui M. Mutation in the epsilon subunit of the cytosolic chaperonin-containing t-complex peptide-1 (Cct5) gene causes autosomal recessive mutilating sensory neuropathy with spastic paraplegia. J Med Genet 2006, 43(5):441-443.
57. Howlett David R. Protein misfolding in disease: cause or response?. Curr Med Chem Immunol Endocr Metab Agents 2003, 3:371-383.
58. Butterfield D.A., Perluigi M., Reed T., Muharib T., Hughes C.P., Robinson R.A., et al. Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications. Antioxid Redox Signal 2012, 17(11):1610-1655.
59. Butterfield D.A., Sultana R. Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: insights into the progression of this dementing disorder. J Alzheimers Dis 2007, 12(1):61-72.
60. Schmidt M.L., Lee V.M., Trojanowski J.Q. Comparative epitope analysis of neuronal cytoskeletal proteins in Alzheimer's disease senile plaque neurites and neuropil threads. Lab Invest 1991, 64(3):352-357.
61. Erikson K.M., Dobson A.W., Dorman D.C., Aschner M. Manganese exposure and induced oxidative stress in the rat brain. Sci Total Environ 2004, 334-335:409-416.
62. Lafon-Cazal M., Fagni L., Guiraud M.J., Mary S., Lerner-Natoli M., Pin J.P., et al. mGluR7-Like metabotropic glutamate receptors inhibit NMDA-mediated excitotoxicity in cultured mouse cerebellar granule neurons. Eur J Neurosci 1999, 11(2):663-672.
63. van Hemert M.J., Steensma H.Y., van Heusden G.P. 14-3-3 proteins: key regulators of cell division, signaling and apoptosis. Bioessays 2001, 23(10):936-946.